Should Citi’s Downgrade and AI Competition Concerns Require Action From DocuSign (DOCU) Investors?

• Earlier in April 2026, Citi Research downgraded DocuSign from Buy to Neutral, pointing to stalled revenue growth around 8% and mounting competitive threats, including AI-native rivals and large software vendors.
• At the same time, insider share sales and concerns that AI could commoditize e-signature tools raised fresh questions about DocuSign’s growth engine and business model resilience.
• We’ll now examine how Citi’s downgrade and worries about AI-driven competition may reshape DocuSign’s previously constructive investment narrative.

Find 57 companies with promising cash flow potential yet trading below their fair value.

DocuSign Investment Narrative Recap

To own DocuSign today, you need to believe its e-signature scale and newer Intelligent Agreement Management platform can offset slower headline growth and rising AI-driven competition. Citi’s downgrade highlights that the short term catalyst around IAM adoption now has to work harder against the biggest risk: that e-signature and workflow tools become commoditized, especially as large vendors and AI native entrants intensify pricing and renewal pressure. The downgrade itself does not change that risk, but it sharpens the focus on it.

Against this backdrop, DocuSign’s March 2026 launch of its Iris powered contract review assistant inside IAM looks especially important. It is a concrete example of the company trying to move beyond basic signatures into higher value AI workflows such as automated redlining and policy checks. If customers embrace these tools, they could support stickier relationships and higher spend per account, which is central to any thesis that DocuSign can grow into its current valuation despite slower top line growth.

But even if IAM gains traction, investors should be aware that intensifying AI driven commoditization risk could still...

Read the full narrative on DocuSign (it's free!)

DocuSign's narrative projects $4.0 billion revenue and $482.3 million earnings by 2029. This requires 7.5% yearly revenue growth and about a $173.2 million earnings increase from $309.1 million today.

Uncover how DocuSign's forecasts yield a $60.16 fair value, a 35% upside to its current price.

Exploring Other Perspectives

Before Citi’s downgrade, the most optimistic analysts were banking on IAM to counter exactly this AI commoditization risk, projecting around US$4.2 billion of revenue and roughly US$490 million of earnings by 2029. Their view is much more optimistic than consensus and could shift meaningfully now that growth has stalled near 8 percent and competitive worries are front and center, so it is worth weighing these different expectations before you decide where you stand.

Explore 7 other fair value estimates on DocuSign - why the stock might be worth over 3x more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your DocuSign research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free DocuSign research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DocuSign's overall financial health at a glance.

Curious About Other Options?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 19 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com